Morgan Stanley 13D and 13G filings for 10x Genomics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-12-08 4:37 pm Sale | 2023-11-30 | 13G | 10x Genomics, Inc. TXG | MORGAN STANLEY MS | 3,630,398 3.500% | -1,509,063 (-29.36%) | Filing |
| 2023-07-10 4:38 pm Sale | 2023-06-30 | 13G | 10x Genomics, Inc. TXG | MORGAN STANLEY MS | 5,139,461 5.200% | -4,755,518 (-48.06%) | Filing |
| 2023-02-08 11:17 am Sale | 2022-12-30 | 13G | 10x Genomics, Inc. TXG | MORGAN STANLEY MS | 9,894,979 10.400% | -446,774 (-4.32%) | Filing |
| 2022-09-12 4:29 pm Purchase | 2022-08-31 | 13G | 10x Genomics, Inc. TXG | MORGAN STANLEY MS | 10,341,753 10.900% | 5,732,995 (+124.39%) | Filing |
| 2022-02-09 10:56 am Sale | 2021-12-31 | 13G | 10x Genomics, Inc. TXG | MORGAN STANLEY MS | 4,608,758 5.000% | -1,306,776 (-22.09%) | Filing |
| 2021-02-10 10:23 am Sale | 2020-12-31 | 13G | 10x Genomics, Inc. TXG | MORGAN STANLEY MS | 5,915,534 7.400% | -877,284 (-12.91%) | Filing |
| 2020-05-08 4:19 pm Purchase | 2020-04-30 | 13G | 10x Genomics, Inc. TXG | MORGAN STANLEY MS | 6,792,818 12.100% | 1,774,572 (+35.36%) | Filing |
| 2020-04-09 4:08 pm Purchase | 2020-03-31 | 13G | 10x Genomics, Inc. TXG | MORGAN STANLEY MS | 5,018,246 23.600% | 3,947,755 (+368.78%) | Filing |